The Market Reports

Index

1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview
1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis (NASH) Biomarkers
1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type
1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Serum Biomarkers
1.2.3 Cytokeratin-18 (CK 18) Marker
1.2.4 Inflammatory Markers
1.2.5 Others
1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application
1.3.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Estimates and Forecasts
1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2016-2027
1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2016-2027
1.4.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competition by Manufacturers
2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2016-2021)
2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites, Area Served, Product Type
2.5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation and Trends
2.5.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players Market Share by Revenue
2.5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario by Region
3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.3.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
3.3.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.4.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
3.4.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Region
3.5.1 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region
3.5.2 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.6.1 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
3.6.2 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country
3.7.2 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Analysis by Type
4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2016-2021)
4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2016-2021)

5 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Historic Market Analysis by Application
5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2016-2021)
5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Biopredictive
6.1.1 Biopredictive Corporation Information
6.1.2 Biopredictive Description and Business Overview
6.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Biopredictive Product Portfolio
6.1.5 Biopredictive Recent Developments/Updates
6.2 Quest Diagnostics
6.2.1 Quest Diagnostics Corporation Information
6.2.2 Quest Diagnostics Description and Business Overview
6.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Quest Diagnostics Product Portfolio
6.2.5 Quest Diagnostics Recent Developments/Updates
6.3 Exalenz Bioscience
6.3.1 Exalenz Bioscience Corporation Information
6.3.2 Exalenz Bioscience Description and Business Overview
6.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Exalenz Bioscience Product Portfolio
6.3.5 Exalenz Bioscience Recent Developments/Updates
6.4 GENFIT
6.4.1 GENFIT Corporation Information
6.4.2 GENFIT Description and Business Overview
6.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GENFIT Product Portfolio
6.4.5 GENFIT Recent Developments/Updates
6.5 Siemens Healthineers
6.5.1 Siemens Healthineers Corporation Information
6.5.2 Siemens Healthineers Description and Business Overview
6.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Siemens Healthineers Product Portfolio
6.5.5 Siemens Healthineers Recent Developments/Updates
6.6 ONE WAY LIVER
6.6.1 ONE WAY LIVER Corporation Information
6.6.2 ONE WAY LIVER Description and Business Overview
6.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.6.4 ONE WAY LIVER Product Portfolio
6.6.5 ONE WAY LIVER Recent Developments/Updates
6.7 Prometheus Laboratories
6.6.1 Prometheus Laboratories Corporation Information
6.6.2 Prometheus Laboratories Description and Business Overview
6.6.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Prometheus Laboratories Product Portfolio
6.7.5 Prometheus Laboratories Recent Developments/Updates
6.8 Gilead Sciences
6.8.1 Gilead Sciences Corporation Information
6.8.2 Gilead Sciences Description and Business Overview
6.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Gilead Sciences Product Portfolio
6.8.5 Gilead Sciences Recent Developments/Updates

7 Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Cost Analysis
7.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
7.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
8.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers

9 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics
9.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Trends
9.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Growth Drivers
9.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges
9.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

10 Global Market Forecast
10.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2022-2027)
10.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2022-2027)
10.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Covered in This Study
Table 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Manufacturers (2016-2021)
Table 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturing Sites and Area Served
Table 11. Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Type
Table 12. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2016-2021) & (K Units)
Table 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
Table 17. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2016-2021) & (K Units)
Table 19. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2016-2021)
Table 20. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2016-2021)
Table 22. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2016-2021) & (K Units)
Table 23. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2016-2021)
Table 24. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2016-2021)
Table 32. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2016-2021)
Table 38. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2016-2021)
Table 39. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2016-2021)
Table 40. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Type (2016-2021)
Table 42. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2016-2021)
Table 43. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2016-2021)
Table 44. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2016-2021)
Table 45. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Application (2016-2021)
Table 47. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2016-2021)
Table 48. Biopredictive Corporation Information
Table 49. Biopredictive Description and Business Overview
Table 50. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 52. Biopredictive Recent Developments/Updates
Table 53. Quest Diagnostics Corporation Information
Table 54. Quest Diagnostics Description and Business Overview
Table 55. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 57. Quest Diagnostics Recent Developments/Updates
Table 58. Exalenz Bioscience Corporation Information
Table 59. Exalenz Bioscience Description and Business Overview
Table 60. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 62. Exalenz Bioscience Recent Developments/Updates
Table 63. GENFIT Corporation Information
Table 64. GENFIT Description and Business Overview
Table 65. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 67. GENFIT Recent Developments/Updates
Table 68. Siemens Healthineers Corporation Information
Table 69. Siemens Healthineers Description and Business Overview
Table 70. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 72. Siemens Healthineers Recent Developments/Updates
Table 73. ONE WAY LIVER Corporation Information
Table 74. ONE WAY LIVER Description and Business Overview
Table 75. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 77. ONE WAY LIVER Recent Developments/Updates
Table 78. Prometheus Laboratories Corporation Information
Table 79. Prometheus Laboratories Description and Business Overview
Table 80. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 82. Prometheus Laboratories Recent Developments/Updates
Table 83. Gilead Sciences Corporation Information
Table 84. Gilead Sciences Description and Business Overview
Table 85. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product
Table 87. Gilead Sciences Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List
Table 91. Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers List
Table 92. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends
Table 93. Non-alcoholic Steatohepatitis (NASH) Biomarkers Growth Drivers
Table 94. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints
Table 95. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Type in 2020 & 2027
Figure 3. Serum Biomarkers Product Picture
Figure 4. Cytokeratin-18 (CK 18) Marker Product Picture
Figure 5. Inflammatory Markers Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Diagnostic Centers
Figure 10. Others
Figure 11. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size 2016-2027 (US$ Million)
Figure 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2016-2027 (K Units)
Figure 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Manufacturers in 2020
Figure 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players: Market Share by Revenue in 2020
Figure 18. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2016-2021)
Figure 20. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region in 2020
Figure 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2016-2021)
Figure 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region in 2020
Figure 23. U.S. Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2016-2021)
Figure 48. Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2016-2021)
Figure 49. Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application in 2020
Figure 50. Revenue Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2016-2021)
Figure 51. Revenue Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application in 2020
Figure 52. Manufacturing Cost Structure of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 53. Manufacturing Process Analysis of Non-alcoholic Steatohepatitis (NASH) Biomarkers
Figure 54. Non-alcoholic Steatohepatitis (NASH) Biomarkers Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed